![(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F478441-mc-310911.webp&w=3840&q=75)
CAS 1000287-05-7
:(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]-6-benzothiazolyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate
Description:
The chemical substance with the name "(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]-6-benzothiazolyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate" and CAS number "1000287-05-7" is a complex organic compound characterized by its multi-cyclic structure and various functional groups. It features a hexahydrofurofuran moiety, which contributes to its potential biological activity. The presence of a carbamate group indicates possible interactions with biological systems, particularly in pharmacology. Additionally, the compound contains a benzothiazole moiety, which is often associated with diverse biological activities, including antimicrobial and anticancer properties. The stereochemistry, indicated by the (R) and (S) designations, suggests that the compound may exhibit specific interactions with biological targets, potentially influencing its efficacy and safety profile. Overall, this compound's intricate structure and functional groups suggest it may have significant applications in medicinal chemistry, particularly in drug development.
Formula:C38H53N5O7S2
InChI:InChI=1S/C38H53N5O7S2/c1-25(2)22-43(23-33(44)32(20-26-8-4-3-5-9-26)41-38(45)50-34-24-49-36-30(34)16-19-48-36)52(46,47)29-12-13-31-35(21-29)51-37(40-31)39-27-14-17-42(18-15-27)28-10-6-7-11-28/h3-5,8-9,12-13,21,25,27-28,30,32-34,36,44H,6-7,10-11,14-20,22-24H2,1-2H3,(H,39,40)(H,41,45)/t30-,32-,33+,34-,36+/m0/s1
InChI key:InChIKey=JQUNFHFWXCXPRK-AMMMHQJVSA-N
SMILES:N(C=1SC=2C(N1)=CC=C(S(N(C[C@H]([C@H](CC3=CC=CC=C3)NC(O[C@@H]4[C@]5([C@@](OC4)(OCC5)[H])[H])=O)O)CC(C)C)(=O)=O)C2)C6CCN(CC6)C7CCCC7
Synonyms:- Carbamic acid, N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]-6-benzothiazolyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
- (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]-6-benzothiazolyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate
- TMC 310911
- ASC 09
- MC-310911
- TMC310911,TMC-310911
- (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazole-6-sulfonamido]-1-phenylbutan-2-yl]carbamate
- (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((2-((1-cyclopentylpiperidin-4-yl)amino)-N-isobutylbenzo[d]thiazole)-6-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(2-((1-cyclopentylpiperidin-4-yl)amino)-N-isobutylbenzo[d]thiazole-6-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
CAS:(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(2-((1-cyclopentylpiperidin-4-yl)amino)-N-isobutylbenzo[d]thiazole-6-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamateFormula:C38H53N5O7S2Purity:99.90%Molecular weight:755.99ASC 09
CAS:ASC 09, also known as TMC-310911, is a protease inhibitor developed to treat HIV infections. Recently, ASC 09 has been evaluated for the treatment of SARS-CoV-2 as it shows potential inhibition in silico of SARS-CoV-2 main protease and SARS-CoV main proteases.
Formula:C38H53N5O7S2Purity:Min. 95%Molecular weight:755.99 g/molTMC310911
CAS:TMC310911 is an oral HIV-1 protease inhibitor with an EC50 of 2.2-14.2 nM, effective against various HIV-1 strains.Formula:C38H53N5O7S2Purity:98%Color and Shape:SolidMolecular weight:755.99
